wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35592307-14B0DD1A-5A66-49AB-A04A-14057E56C9CE
Q35592307-14B0DD1A-5A66-49AB-A04A-14057E56C9CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35592307-14B0DD1A-5A66-49AB-A04A-14057E56C9CE
Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective.
P2860
Q35592307-14B0DD1A-5A66-49AB-A04A-14057E56C9CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35592307-14B0DD1A-5A66-49AB-A04A-14057E56C9CE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2f93b52847a2f467369c55e1343ea5e258615252
P2860
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.